| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 108 | 947 | 263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 108 | 947 | 263 | 0 | 1.855 | 0 | 116 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.950 | 2.012 | 7.300 | 1.486 | 1.972 | 854 | 1.074 | 914 | 214 | 687 |
| Gross Profit/Loss - EUR | -5.842 | -1.065 | -7.037 | -1.486 | -117 | -854 | -958 | -914 | -214 | -687 |
| Net Profit/Loss - EUR | -5.845 | -1.094 | -7.045 | -1.486 | -117 | -854 | -958 | -914 | -214 | -687 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Romintermed Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 832 | 570 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 74 | 3.979 | 1.217 | 1.250 | 648 | 637 | 1.131 | 1.432 | 3.254 | 2.549 |
| Inventories | 0 | 3.192 | 0 | 70 | 0 | 0 | 507 | 815 | 812 | 808 |
| Receivables | 67 | 780 | 1.195 | 1.173 | 642 | 630 | 616 | 617 | 616 | 612 |
| Cash | 7 | 7 | 22 | 6 | 6 | 7 | 9 | 0 | 1.827 | 1.130 |
| Shareholders Funds | -73.985 | -74.324 | -80.112 | -80.128 | -78.693 | -78.055 | -77.282 | -78.436 | -78.413 | -78.661 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 74.890 | 78.873 | 81.329 | 81.378 | 79.341 | 78.692 | 78.414 | 79.868 | 81.667 | 81.211 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Romintermed Company Srl